<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03146481</url>
  </required_header>
  <id_info>
    <org_study_id>CEBD-CU-2015-5-145</org_study_id>
    <nct_id>NCT03146481</nct_id>
  </id_info>
  <brief_title>Pre-operative Aceclofenac on the Anesthetic Efficacy of IANB in Symptomatic Irreversible Pulpitis</brief_title>
  <official_title>Effect of Pre-operative Aceclofenac on the Anesthetic Efficacy of Inferior Alveolar Nerve Block in Patients With Symptomatic Irreversible Pulpitis: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomized, double-blinded, controlled study is to evaluate the effect of
      pre-operative oral aceclofenac on the success of the inferior alveolar nerve block with 2%
      Mepivacaine containing 100,000 Epinephrine for patients with symptomatic irreversible
      pulpitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  The aim of this randomized, double-blinded, controlled study is to evaluate the effect
           of pre-operative oral aceclofenac on the success of the inferior alveolar nerve block
           with 2% Mepivacaine containing 100,000 Epinephrine for patients with symptomatic
           irreversible pulpitis.

        -  Patients will be clinically and radiographically examined and their eligibility will be
           assessed and preoperative pain will be measured using Heft-Parker VAS. Eligible patients
           will be treated in one visit.

        -  Patients will be randomly assigned to one of 2 groups: experimental group (taking a 100
           mg of Aceclofenac) and the control group (taking a placebo tablet). Each tablet will be
           taken one hour before starting treatment. After 15 minutes of the initial inferior
           alveolar nerve block (IANB), the teeth will be examined using a cold pulp sensitivity
           test; in case of no or mild pain, the treatment will be initiated otherwise, additional
           IANB will be administered.

        -  During root canal treatment, no to mild pain response will be considered success. In
           case of failure, supplemental anesthesia will be administrated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">July 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anesthetic success</measure>
    <time_frame>intraoperative</time_frame>
    <description>Success of mandibular inferior alveolar nerve block anesthesia during access cavity preparation and instrumentation which will be measured with Heft-parker VAS in which no or mild pain will be considered as anesthetic success and moderate or severe pain will be considered as anesthetic failure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain on injection of inial IANB</measure>
    <time_frame>intraoperative</time_frame>
    <description>Pain on injection of inial IANB will be measured with Heft-Parker VAS</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Irreversible Pulpitis</condition>
  <arm_group>
    <arm_group_label>Aceclofenac</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aceclofenac 100 mg tablet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aceclofenac</intervention_name>
    <description>Aceclofenac 100 mg tablet given one hour before starting the root canal treatment</description>
    <arm_group_label>Aceclofenac</arm_group_label>
    <other_name>Bristaflam</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo tablet given one hour before starting the root canal treatment</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients in good health (American Society of Anesthesiologists Class I or Class II).

          -  Patients having symptomatic irreversible pulpitis in one of their mandibular molars

          -  Age is 18 years or older.

          -  Patients who can understand Heft- Parker Visual Analogue Scales.

          -  Patients able to sign informed consent.

        Exclusion Criteria:

          -  Patients allergic to aceclofenac or Mepivacaine.

          -  Pregnant or nursing women.

          -  Patients having active pain in more than one molar in the same quadrant.

          -  Administration of analgesics within 12 h before the administration of the study drug.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nermeen A Abbas, Postgraduate</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Suzan AW Amin, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shaimaa Gawdat, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <zip>11553</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Ramachandran A, Khan SI, Mohanavelu D, Kumar KS. The efficacy of pre-operative oral medication of paracetamol, ibuprofen, and aceclofenac on the success of maxillary infiltration anesthesia in patients with irreversible pulpitis: A double-blind, randomized controlled clinical trial. J Conserv Dent. 2012 Oct;15(4):310-4. doi: 10.4103/0972-0707.101881.</citation>
    <PMID>23112474</PMID>
  </reference>
  <reference>
    <citation>Jena A, Shashirekha G. Effect of preoperative medications on the efficacy of inferior alveolar nerve block in patients with irreversible pulpitis: A placebo-controlled clinical study. J Conserv Dent. 2013 Mar;16(2):171-4. doi: 10.4103/0972-0707.108209.</citation>
    <PMID>23716973</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 7, 2017</study_first_submitted>
  <study_first_submitted_qc>May 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 10, 2017</study_first_posted>
  <last_update_submitted>November 4, 2017</last_update_submitted>
  <last_update_submitted_qc>November 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Nermeen AwadAllah Abbas Ibrahim</investigator_full_name>
    <investigator_title>Principal Investigator, Cairo University</investigator_title>
  </responsible_party>
  <keyword>Anesthetic efficacy, Irriversible pulpitis, Aceclofenac</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulpitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Aceclofenac</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

